- Science
- Clinical Trials
- Guide to Clinical Trials Your participation makes a difference
- Clinical Trials in Children Designed to improve kids' health
- Data and Results Sharing our Results
- Integrity and Transparency Building Trust
- Diversity Equity and Representation
- Plain Language Study Results Trial Result Summaries
- Expanded Access & Compassionate Use Possible Treatment Options
- Find a Trial
- Areas of Focus
- Rare Disease Smaller populations but big impact
- Internal Medicine Extending lifespans worldwide
- Inflammation & Immunology Treatment at the molecular level
- Vaccines Preventing the spread of infections
- Oncology The science of optimism
- Anti Infectives Combatting an evolving risk
- Areas of Innovation
- Gene Therapy Breakthroughs become treatments
- Medicinal Sciences The next generation of science
- Precision Medicine Developing tailored medicines
- Maternal Immunization Protecting newborns at the start
- mRNA Technology Unleashing the next wave of scientific innovations
- Diseases & Conditions
- Coronavirus Resources
- Product Pipeline
- Research Sites
- Clinical Trials
- Products
- How Drugs are Made
- Branded vs. Generic Learn the difference
- Biologics & Biosimilars Cures found in nature
- Commitment to Quality Maintaining the highest standards
- Global Supply Strategic manufacturing locations
- Manufacturing Sites Where medicine is made in the U.S.
- Medicine Safety
- Health Literacy Learning to be well
- Treatment Choices Learning about treatment decisions
- Partnering With Patients Helping others by reporting side effects
- Tips for Patients Preventing medication errors
- Reporting Adverse Events
- Counterfeiting Preventing medication errors
- Product Safety
- Product List
- Product Contacts
- PfizerPro for Professionals
- Patient Assistance Programs
- Distributors
- How Drugs are Made
- Stories
- Newsroom
- About
- People
- Executives Our senior-most leadership
- Board Members The people steering our company
- Scientists Our experts making discoveries
- Patient Stories Our patients
- Colleague Stories Our colleagues
- Responsibility
- Ethics & Compliance Each of us is responsible
- Responsible Business Breakthroughs that change patients’ lives
- Patient Advocacy & Engagement Putting Patients First
- Global Impact Meeting urgent needs worldwide
- Diversity, Equity, and Inclusion Everyone has something to offer
- Environmental Sustainability Our responsiblity to the environment
- Human Rights Furthering dignity and worth
- Health & Safety
- Intellectual Property The benefits of fair competition
- EHS Governance
- Misinformation
- Programs & Policies
- Grants Support for independent research
- Political Partnership Supporting like-minded organizations
- Working with Healthcare Professionals Collaboration to improve lives
- Prescription Value & Pricing How to lower patient costs
- Privacy Principles Commitment to personal data privacy
- Ready for Cures Improving Access to Medicines
- Transparency in Grants Committed to Disclosure
- Policy Positions
- Investors
- Investors Overview Information for stockholders
- Why Invest Why to join us in our mission
- Events & Presentations Calendar of upcoming events
- Financial Reports Quarterly reports and more
- Investor News Announcements about our performance
- Stock Information Charts and data
- Shareholder Services Information on stock transactions
- Corporate Governance
- Corporate Governance Overview Gaining insight into our performance
- Board Committees & Charters Defining the corporate structure
- The Pfizer Board Policies Ensuring ethical leadership
- Corporate Governance FAQs Learn more about our approach
- Contact Our Directors Email any of our Directors
- Purpose
- History
- Careers
- Partners
- People
We Believe in Expanding Cancer Advocacy and Support
Pfizer advocates for the cancer community to support the needs of all that are impacted by cancer along with the encouragement to join forces.
Supporting the needs of patients
We work closely with patient advocates, professional organizations, policy makers, and foundations to better understand the needs of patients, families, caregivers, and others impacted by cancer and find ways to meet those needs.
We encourage our partners to share best practices and work together to achieve patient-centric solutions. Our goal is to provide the educational, emotional, and psychosocial resources that can make a real difference in patient outcomes.
We also provide millions of dollars in grants each year to fund organizations that provide essential programs and services to patients coping with a wide range of cancers.
- Change the Odds: The American Cancer Society and Pfizer
The American Cancer Society (ACS) and Pfizer recently launched a new three-year initiative
The American Cancer Society (ACS) and Pfizer recently launched a new three-year initiative, “Change the Odds: Uniting to Improve Cancer Outcomes,” aimed at addressing cancer disparities and improving health outcomes in medically underrepresented communities across the United States. - Lung Cancer Profiles/United We Test Quest
Lung Cancer Profiles/United We Test Quest
Collaborated with 7 lung cancer patient advocacy organizations toincrease awareness and education. - AVON Foundation for Women
AVON Foundation for Women
Established a grants program with Avon Foundation to support people living with metastatic breast cancer. In 2015, Avon and Pfizer each contributed $500,000 in grants that were awarded to a total of 23 nonprofit organizations. - Breast Cancer: A Story Half Told
Breast Cancer: A Story Half Told
Partnered with 5 patient advocacy organizations, healthcare professionals, linguists, and employers to support women with breast cancer, including those with metastatic disease - Cancer Support Community (CSC)/The Leukemia & Lymphoma Society (LLS)
Cancer Support Community (CSC)/The Leukemia & Lymphoma Society (LLS)
Collaborated with the Chronic Myeloid Leukemia (CML) Patient Experience Registry to identify and understand the psychosocial and emotional needs of CML patients. - ASCO/Conquer Cancer Foundation (CCF)
ASCO/Conquer Cancer Foundation (CCF)
Supported the CancerLinQ initiative, a health information technology (HIT) platform designed to improve the quality and value of cancer care. - Union for International Cancer Control (UICC)
Union for International Cancer Control (UICC)
Supported a first-of-its-kind initiativeto address the unique challenges facing metastatic breast cancer (MBC) patients. - Susan G. Komen
Susan G. Komen
Supported the Komen Disparities initiative to reduce the difference in breast cancer outcomes between African-American and Caucasian women in the US.
Joining forces to speed advances and breakthrough medicines to patients
At Pfizer, we know we can’t go at it alone and are actively supporting the development of an emerging, highly networked ecosystem that will catalyze tomorrow’s health innovation.
This includes working with patient foundations, patients, government, payers, healthcare professionals, academia, and even some of our competitors in the biopharmaceutical industry.
Challenging our colleagues to do more
The Global Health Fellows (GHF) program is an international corporate volunteer program that places Pfizer colleagues in short-term fellowships with international development organizations. Fellows return with experience and relationships that help inform their ability to have an impact on pressing health concerns and to do business more efficiently.
Learn more about the Global Health Fellows program
Supporting women with metastatic breast cancer (MBC)
In 2015, to address the unique needs of MBC patients worldwide, Pfizer and the UICCa awarded grants totaling $760,000 to 20 organizations from 18 countries under a first-of-its-kind initiative, SPARCb-MBC Challenge.
The challenge aims to empower advocacy groups, hospital networks, support groups, and other organizations to close the gap in information, support, awareness, and policy between MBC and early stage disease, and support women diagnosed with metastatic breast cancer.
aUnion for International Cancer Control
bSeeding Progress and Resources for the Cancer Community.
